Labeler
Apotex Corp. NDC Codes
Apotex Corp. lists 344 finished drug products in the FDA NDC Directory under NDC labeler code 60505.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Dexamethasone, Lisdexamfetamine Dimesylate, Dasatinib, Brivaracetam, Ceftaroline Fosamil, Pomalidomide, Nuvigil, Eslicarbazepine Acetate, Tofacitinib, Sitagliptin, Nilotinib, Oxcarbazepine, dabigatran etexilate, Sitagliptin and Metformin Hydrochloride, Dapagliflozin
- Active ingredients
- Dexamethasone, Lisdexamfetamine dimesylate, Dasatinib, Sitagliptin phosphate, Brivaracetam, Ceftaroline fosamil, Pomalidomide, Armodafinil, Eslicarbazepine acetate, Nilotinib, Oxcarbazepine, Dabigatran etexilate mesylate
- NDC labeler codes
- 60505
- Strengths (from the 100 most recently listed products)
- Sitagliptin phosphate 50 mg/1; Ceftaroline fosamil 400 mg/20mL; Ceftaroline fosamil 600 mg/20mL; Eribulin mesylate .5 mg/mL; Trabectedin .05 mg/mL; Hydrocortisone sodium succinate 100 mg/2mL; Macitentan 10 mg/1; Tofacitinib citrate 11 mg/1; Tofacitinib 10 mg/1; Tofacitinib 5 mg/1; Sitagliptin phosphate 100 mg/1; Metformin hydrochloride 500 mg/1; Metformin hydrochloride 1000 mg/1; Sitagliptin phosphate 25 mg/1; Dapagliflozin 10 mg/1; Dapagliflozin 5 mg/1; Nintedanib esylate 100 mg/1; Nintedanib esylate 150 mg/1; Pomalidomide 3 mg/1; Pomalidomide 1 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Capsule, Kit, Injection, Powder, Lyophilized, For solution, Injection, Injection, Solution, Tablet, Extended release, Injection, Powder, For solution, Injection, Solution, Concentrate, Tablet, Film coated, Extended release, Solution/ drops, Spray, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Ophthalmic, Nasal
- Drug classes (FDA established)
- Kinase Inhibitor, Corticosteroid, Central Nervous System Stimulant, Cephalosporin Antibacterial, Dipeptidyl Peptidase 4 Inhibitor, Thalidomide Analog, Janus Kinase Inhibitor, P2Y12 Platelet Inhibitor, Anti-epileptic Agent, Direct Thrombin Inhibitor, Alkylating Drug, Biguanide, Sodium-Glucose Cotransporter 2 Inhibitor, Sympathomimetic-like Agent, Serotonin-4 Receptor Agonist, Microtubule Inhibitor, Copper Absorption Inhibitor, Platinum-based Drug, Pyridone, Endothelin Receptor Antagonist, Macrolide Antibacterial, Purine Antimetabolite, Serotonin-3 Receptor Antagonist, Factor Xa Inhibitor, Pharmacologic Cardiac Stress Test Agent, Tetracycline-class Drug, Nonsteroidal Anti-inflammatory Drug, Nucleoside Metabolic Inhibitor, Melatonin Receptor Agonist, Parathyroid Hormone Analog
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 125 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Irinotecan Hydrochloride | Irinotecan hydrochloride 20 mg/mL | Injection, SolutionIntravenous | 60505-6128 | 60505-6128-0060505-6128-01 | — |
| Cefepime | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | 60505-6145 | 60505-6145-04 | — |
| Cefepime | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6144 | 60505-6144-04 | — |
| Prasugrel | Prasugrel hydrochloride 5 mg/1 | Tablet, Film coatedOral | 60505-4642 | 60505-4642-03 | — |
| Prasugrel | Prasugrel hydrochloride 10 mg/1 | Tablet, Film coatedOral | 60505-4643 | 60505-4643-03 | — |
| Fluticasone Propionate | Fluticasone propionate 50 ug/1 | Spray, MeteredNasal | 60505-0955 | 60505-0955-0160505-0955-03 | — |
| Moxifloxacin | Moxifloxacin hydrochloride monohydrate 5 mg/mL | Solution/ dropsOphthalmic | 60505-0582 | 60505-0582-04 | — |
| Cefazolin | Cefazolin sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6142 | 60505-6142-05 | — |
| Ceftriaxone Sodium | Ceftriaxone sodium 2 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6149 | 60505-6149-04 | J0696 |
| Ceftriaxone Sodium | Ceftriaxone sodium 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6148 | 60505-6148-0060505-6148-04 | J0696 |
| Ceftriaxone Sodium | Ceftriaxone sodium 500 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6152 | 60505-6152-0160505-6152-04 | J0696 |
| Ceftriaxone Sodium | Ceftriaxone sodium 250 mg/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6151 | 60505-6151-0160505-6151-04 | J0696 |
| Cefepime | Cefepime hydrochloride 1 g/1 | Injection, Powder, For solutionIntramuscular, Intravenous | 60505-6146 | 60505-6146-0060505-6146-04 | — |
| Cefepime | Cefepime hydrochloride 2 g/1 | Injection, Powder, For solutionIntravenous | 60505-6147 | 60505-6147-0060505-6147-04 | — |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | 60505-6132 | 60505-6132-0660505-6132-0760505-6132-08 | — |
| Imatinib Mesylate | Imatinib mesylate 400 mg/1 | Tablet, Film coatedOral | 60505-2901 | 60505-2901-0060505-2901-0160505-2901-03+2 more | — |
| Imatinib Mesylate | Imatinib mesylate 100 mg/1 | Tablet, Film coatedOral | 60505-2900 | 60505-2900-0060505-2900-0160505-2900-03+2 more | — |
| Ondansetron | Ondansetron hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous | 60505-6130 | 60505-6130-05 | J2405 |
| Budesonide | Budesonide 32 ug/1 | Spray, MeteredNasal | 60505-6129 | 60505-6129-0260505-6129-0660505-6129-07 | — |
| Mometasone Furoate | Mometasone 50 ug/1 | Spray, MeteredNasal | 60505-0830 | 60505-0830-01 | — |
| Ibandronate Sodium | Ibandronate sodium 3 mg/3mL | InjectionIntravenous | 60505-6097 | 60505-6097-00 | — |
| Risedronate Sodium | Risedronate sodium 35 mg/1 | Tablet, Film coatedOral | 60505-3165 | 60505-3165-0060505-3165-02 | — |
| aripiprazole | Aripiprazole 1 mg/mL | SolutionOral | 60505-0404 | 60505-0404-05 | — |
| Celecoxib | Celecoxib 100 mg/1 | CapsuleOral | 60505-3848 | 60505-3848-01 | — |
| Celecoxib | Celecoxib 200 mg/1 | CapsuleOral | 60505-3849 | 60505-3849-0160505-3849-05 | — |
| Levetiracetam | Levetiracetam 1000 mg/1 | Tablet, Film coated, Extended releaseOral | 60505-3518 | 60505-3518-06 | — |
| Olopatadine Hydrochloride | Olopatadine hydrochloride 665 ug/1 | Spray, MeteredNasal | 60505-0845 | 60505-0845-05 | — |
| Mycophenolic Acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 60505-2966 | 60505-2966-07 | — |
| Risedronate Sodium | Risedronate sodium 75 mg/1 | Tablet, Film coatedOral | 60505-3096 | 60505-3096-02 | — |
| Risedronate Sodium | Risedronate sodium 150 mg/1 | Tablet, Film coatedOral | 60505-3097 | 60505-3097-0260505-3097-04 | — |
| Clopidogrelclopidogrel bisulfate | Clopidogrel bisulfate 300 mg/1 | Tablet, Film coatedOral | 60505-3532 | 60505-3532-05 | — |
| Modafinil | Modafinil 100 mg/1 | TabletOral | 60505-2526 | 60505-2526-0160505-2526-03 | — |
| Modafinil | Modafinil 200 mg/1 | TabletOral | 60505-2527 | 60505-2527-0160505-2527-03 | — |
| Lamivudine | Lamivudine 100 mg/1 | Tablet, Film coatedOral | 60505-3250 | 60505-3250-06 | — |
| Fenofibrate | Fenofibrate 130 mg/1 | CapsuleOral | 60505-3121 | 60505-3121-0160505-3121-0360505-3121-05+1 more | — |
| Fenofibrate | Fenofibrate 43 mg/1 | CapsuleOral | 60505-3120 | 60505-3120-0160505-3120-03 | — |
| Mycophenolic Acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 60505-2965 | 60505-2965-07 | — |
| Atorvastatin Calcium | Atorvastatin calcium propylene glycol solvate 10 mg/1 | Tablet, Film coatedOral | 60505-2578 | 60505-2578-0060505-2578-0360505-2578-05+3 more | — |
| Atorvastatin Calcium | Atorvastatin calcium propylene glycol solvate 20 mg/1 | Tablet, Film coatedOral | 60505-2579 | 60505-2579-0060505-2579-0360505-2579-05+3 more | — |
| Atorvastatin Calcium | Atorvastatin calcium propylene glycol solvate 40 mg/1 | Tablet, Film coatedOral | 60505-2580 | 60505-2580-0060505-2580-0360505-2580-05+3 more | — |
| Atorvastatin Calcium | Atorvastatin calcium propylene glycol solvate 80 mg/1 | Tablet, Film coatedOral | 60505-2671 | 60505-2671-0060505-2671-0360505-2671-05+3 more | — |
| Clopidogrelclopidogrel bisulfate | Clopidogrel bisulfate 75 mg/1 | Tablet, Film coatedOral | 60505-0253 | 60505-0253-0260505-0253-03 | — |
| ziprasidone hydrochlorideziprasidone hcl | Ziprasidone hydrochloride 40 mg/1 | CapsuleOral | 60505-2529 | 60505-2529-06 | — |
| ziprasidone hydrochlorideziprasidone hcl | Ziprasidone hydrochloride 20 mg/1 | CapsuleOral | 60505-2528 | 60505-2528-06 | — |
| ziprasidone hydrochlorideziprasidone hcl | Ziprasidone hydrochloride 60 mg/1 | CapsuleOral | 60505-2530 | 60505-2530-06 | — |
| ziprasidone hydrochlorideziprasidone hcl | Ziprasidone hydrochloride 80 mg/1 | CapsuleOral | 60505-2531 | 60505-2531-06 | — |
| Olanzapine | Olanzapine 7.5 mg/1 | Tablet, Film coatedOral | 60505-3112 | 60505-3112-0060505-3112-08 | — |
| Olanzapine | Olanzapine 2.5 mg/1 | Tablet, Film coatedOral | 60505-3110 | 60505-3110-0060505-3110-0360505-3110-08 | — |
| Olanzapine | Olanzapine 5 mg/1 | Tablet, Film coatedOral | 60505-3111 | 60505-3111-0060505-3111-08 | — |
| Olanzapine | Olanzapine 10 mg/1 | Tablet, Film coatedOral | 60505-3113 | 60505-3113-0060505-3113-08 | — |
Apotex Corp.: common questions
- What is Apotex Corp.'s NDC labeler code?
- 60505. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Apotex Corp.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.